| |
| |
|
| Insider
Information: |
Erbez Georgia |
| Relationship: |
Chief Financial Officer |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
200,542 |
|
|
Indirect Shares
|
25,915 |
|
|
| Direct
Value |
$81,904 |
|
|
|
Indirect Value
|
$23,163 |
|
|
| Total
Shares |
226,457 |
|
|
| Total
Value |
$105,067 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
0
|
|
Stock
price went up :
|
4
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
4.0
|
0.0
|
| Percentage
Gain/Loss : |
 35.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Zosano Pharma Corp |
ZSAN |
CFO and Chief Business... |
2017-05-25 |
115,750 |
2016-08-19 |
0 |
Premium* |
|
|
Artelo Biosciences, Inc. |
ARTL |
|
2019-06-21 |
12,500 |
|
0 |
Premium* |
|
|
Harpoon Therapeutics, Inc. |
HARP |
Chief Financial Officer |
2021-09-22 |
72,292 |
2021-09-22 |
25,915 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HARP |
Harpoon Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2021-09-22 |
4 |
B |
$8.10 |
$83,430 |
I/I |
10,300 |
19,215 |
1.99 |
% |
|
| HARP |
Harpoon Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2021-02-17 |
4 |
OE |
$2.12 |
$53,000 |
D/D |
25,000 |
72,292 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-08-19 |
4 |
B |
$11.40 |
$57,000 |
I/I |
5,000 |
8,915 |
1.99 |
% |
|
| HARP |
Harpoon Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-08-18 |
4 |
B |
$11.60 |
$24,337 |
I/I |
2,098 |
3,915 |
1.99 |
% |
|
| HARP |
Harpoon Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-07-31 |
4 |
B |
$10.92 |
$19,842 |
I/I |
1,817 |
1,817 |
1.99 |
% |
|
| HARP |
Harpoon Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2020-01-21 |
4 |
B |
$14.09 |
$94,418 |
I/I |
6,700 |
6,700 |
1.99 |
% |
|
| HARP |
Harpoon Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2019-12-04 |
4 |
OE |
$2.12 |
$100,259 |
D/D |
47,292 |
47,292 |
0 |
- |
|
| ARTL |
Artelo Biosciences, Inc. |
|
– • – |
2019-06-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,500 |
|
- |
|
| ZSAN |
Zosano Pharma Corp |
CFO and Chief Business Officer |
• – – |
2017-05-25 |
4 |
B |
$1.32 |
$89,760 |
D/D |
68,000 |
115,750 |
2.74 |
- |
|
| ZSAN |
Zosano Pharma Corp |
Interim CFO |
• – – |
2016-08-19 |
4 |
B |
$1.32 |
$63,030 |
D/D |
47,750 |
47,750 |
2.74 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
